Form 4: Healthcare Services Group Director Acquires Shares Through Deferred Stock Unit Grant

Healthcare Services Group Inc. Director Daniela Castagnino acquired 2,806 unvested deferred stock units at $14.26 per share, increasing her beneficial ownership to 13,006 shares.

Summary

• Director Daniela Castagnino of Healthcare Services Group Inc. (HCSG) acquired 2,806 shares on May 27, 2025.
• The acquisition was a grant of unvested deferred stock units (DSUs) at a price of $14.26 per unit.
• These DSUs are scheduled to become fully vested on the one-year anniversary of the grant date.
• Settlement of the DSUs into shares of common stock will occur on the earliest of: the five-year anniversary of the grant date, the participant's date of death, disability, or separation from service, or the date of a Change of Control.
• Following this transaction, Ms. Castagnino's total beneficial ownership in HCSG stands at 13,006 shares, which includes the 2,806 newly acquired unvested DSUs and 10,200 previously vested DSUs.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through a DSU grant, generally indicates confidence in the company's future prospects and aligns management incentives with shareholder interests. It's a positive signal, though not a direct open-market purchase.

Positives

• The grant of deferred stock units to a director aligns their long-term interests with those of shareholders, incentivizing sustained company performance.
• The acquisition by an insider, even through a compensation grant, can signal confidence in the company's future prospects.

Risks

• The ultimate value realized from the DSUs is dependent on the future market price of Healthcare Services Group Inc. common stock, exposing the director to market risk.
• The vesting and settlement of the DSUs are subject to specific conditions, including a one-year vesting period and various settlement triggers, which could affect the timing of share receipt.

Future Outlook

The document itself does not provide a future outlook for the company's performance or operations. However, the structure of the DSU grant, with its vesting and settlement conditions, implies a long-term retention strategy for the director.

Industry Context

This Form 4 filing details a routine insider compensation event, specifically the grant of deferred stock units to a director. Such compensation structures are common across various industries, including healthcare services, as a means to align the interests of company leadership with long-term shareholder value and to retain key talent.

Comparison to Industry Standards

• The use of deferred stock units (DSUs) as a component of director compensation is a widely adopted practice among publicly traded companies, including those in the healthcare services sector, aligning with corporate governance best practices for incentivizing long-term performance and retention.
• Specific comparisons of the grant value or number of units to peer companies in the healthcare services industry would require additional data not provided in this filing.

Corporate Governance

Stakeholder Impact

• Shareholders: The DSU grant aligns the director's long-term interests with shareholder value, potentially fostering more strategic decision-making focused on sustained growth.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The 2,806 unvested DSUs will become fully vested on the one-year anniversary of the grant date (May 27, 2026).
• Settlement of the DSUs into common stock will occur on the earliest of: the five-year anniversary of the grant date, the participant's date of death, disability, or separation from service, or the date of a Change of Control.

Key Dates

Recommendation

Keywords

Healthcare Services Group, HCSG, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, DSU, Executive Compensation, Corporate Governance